Mast Therapeutics Inc

Available to platforms

Mast Therapeutics Inc. (Ticker: MSTX) was a biopharmaceutical company focused on developing therapies for serious or life-threatening diseases. Its lead product candidate, vepoloxamer, was investigated as a treatment for sickle cell disease and heart failure. In 2017, Mast Therapeutics merged with Savara Inc., a company specializing in therapies for rare respiratory diseases, marking a strategic shift toward advancing treatments for orphan lung conditions.

Mast Therapeutics Inc - MSTX stocks live chart

Analyze price movements of Mast Therapeutics Inc online with R StocksTrader stock charts. You don't need to refresh chart as the quotes are updated automatically. View the current and previous MSTX quotes, get all necessary information for adding Mast Therapeutics Inc to your investment portfolio.

You can invest in Mast Therapeutics Inc and real stocks and CFDs on stocks of other American and European companies in R StocksTrader. Stocks, Indices, Metals: 12,000 assets in total are available for trading in the web terminal. Explore price movements of popular assets, like Mast Therapeutics Inc, in our "Charts" section and expand your trading opportunities by investing in new instruments.

Risk Warning: past performance of MSTX does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Mast Therapeutics Inc (MSTX).

You can trade Mast Therapeutics Inc (MSTX) on the R StocksTrader platform.

You can trade online Mast Therapeutics Inc (MSTX) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts